Curated metabolic health research from PubMed and leading YouTube channels
Subscribe via RSSShowing 1-2 of 2 articles
Chitosan nanoparticles show promise in enhancing the delivery of natural antioxidants for liver health, potentially improving conditions like MASLD and NAFLD.
Research reveals that gut microbiome dysbiosis in MASLD patients increases liver damage and infection risk, highlighting the need for microbiome-focused interventions.